{"id":"https://openalex.org/W4387980411","doi":"https://doi.org/10.1183/13993003.congress-2023.pa4719","title":"Eosinophils sub-types in patients with severe asthma treated with monoclonal antibodies.","display_name":"Eosinophils sub-types in patients with severe asthma treated with monoclonal antibodies.","publication_year":2023,"publication_date":"2023-09-09","ids":{"openalex":"https://openalex.org/W4387980411","doi":"https://doi.org/10.1183/13993003.congress-2023.pa4719"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2023.pa4719","doi":"https://doi.org/10.1183/13993003.congress-2023.pa4719","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa4719","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047901846","display_name":"Carlos Cabrera-L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098027","display_name":"Hospital Universitario de Gran Canaria Doctor Negr\u00edn","ror":"https://ror.org/00s4vhs88","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098027"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Cabrera-L\u00f3pez","raw_affiliation_strings":["Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Pulmonary Department., Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Pulmonary Department., Canary Islands, Spain","institution_ids":["https://openalex.org/I4210098027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072726463","display_name":"Alejandra S\u00e1nchez\u2010Santos","orcid":"https://orcid.org/0009-0000-7725-6731","observed_orcids":["https://orcid.org/0009-0000-7725-6731"]},"institutions":[{"id":"https://openalex.org/I4210098027","display_name":"Hospital Universitario de Gran Canaria Doctor Negr\u00edn","ror":"https://ror.org/00s4vhs88","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098027"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alejandra S\u00e1nchez-Santos","raw_affiliation_strings":["Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Investigation Unit., Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Investigation Unit., Canary Islands, Spain","institution_ids":["https://openalex.org/I4210098027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065195299","display_name":"Angelina Lemes Castellano","orcid":"https://orcid.org/0000-0001-5417-0193","observed_orcids":["https://orcid.org/0000-0001-5417-0193"]},"institutions":[{"id":"https://openalex.org/I4210098027","display_name":"Hospital Universitario de Gran Canaria Doctor Negr\u00edn","ror":"https://ror.org/00s4vhs88","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098027"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Angelina Lemes-Catellano","raw_affiliation_strings":["Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Hematology Department., Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Hematology Department., Canary Islands, Spain","institution_ids":["https://openalex.org/I4210098027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085936108","display_name":"Sara Cazorla-Rivero","orcid":"https://orcid.org/0000-0001-5481-7807","observed_orcids":["https://orcid.org/0000-0001-5481-7807"]},"institutions":[{"id":"https://openalex.org/I4210098027","display_name":"Hospital Universitario de Gran Canaria Doctor Negr\u00edn","ror":"https://ror.org/00s4vhs88","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098027"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sara Cazorla-Rivero","raw_affiliation_strings":["Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Investigation Unit., Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario de Gran Canaria Dr. Negr\u00edn. Investigation Unit., Canary Islands, Spain","institution_ids":["https://openalex.org/I4210098027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065112437","display_name":"Enrique Gonz\u00e1lez\u2010D\u00e1vila","orcid":"https://orcid.org/0000-0002-0781-9161","observed_orcids":["https://orcid.org/0000-0002-0781-9161"]},"institutions":[{"id":"https://openalex.org/I4210088232","display_name":"Hospital Universitario Nuestra Se\u00f1ora de Candelaria","ror":"https://ror.org/005a3p084","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210088232"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enrique Gonz\u00e1lez-D\u00e1vila","raw_affiliation_strings":["Hospital Universitario Nuestra Se\u00f1ora de la Candelaria. Investigation Unit, Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Nuestra Se\u00f1ora de la Candelaria. Investigation Unit, Canary Islands, Spain","institution_ids":["https://openalex.org/I4210088232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008555938","display_name":"Bartolom\u00e9 R. Celli","orcid":"https://orcid.org/0000-0002-7266-8371","observed_orcids":["https://orcid.org/0000-0002-7266-8371"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bartolom\u00e9 Celli","raw_affiliation_strings":["Pulmonary Department, Brigham and Women\u2019s Hospital. Harvard Medical School, Boston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Department, Brigham and Women\u2019s Hospital. Harvard Medical School, Boston, United States","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005845040","display_name":"Ciro Casanova-Macario","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088232","display_name":"Hospital Universitario Nuestra Se\u00f1ora de Candelaria","ror":"https://ror.org/005a3p084","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210088232"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ciro Casanova-Macario","raw_affiliation_strings":["Hospital Universitario Nuestra Se\u00f1ora de la Candelaria. Pulmonary Department., Canary Islands, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Nuestra Se\u00f1ora de la Candelaria. Pulmonary Department., Canary Islands, Spain","institution_ids":["https://openalex.org/I4210088232"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4719","last_page":"PA4719"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12528","display_name":"IL-33, ST2, and ILC Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12538","display_name":"Eosinophilic Esophagitis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eosinophils","display_name":"eosinophils","score":0.9520000219345093},{"id":"https://openalex.org/keywords/severe-asthma","display_name":"severe asthma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/mepolizumab","display_name":"mepolizumab","score":0.9769999980926514},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":1.0},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.7839999794960022},{"id":"https://openalex.org/keywords/siglec-8","display_name":"Siglec-8","score":0.9340000152587891},{"id":"https://openalex.org/keywords/l-selectin","display_name":"L-selectin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/il-3-receptor","display_name":"IL-3 receptor","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cd11b","display_name":"CD11b","score":0.9819999933242798},{"id":"https://openalex.org/keywords/il-5-receptor","display_name":"IL-5 receptor","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.9699988961219788},{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.8129599690437317},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6597321033477783},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.6436119675636292},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6209385991096497},{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.5614928603172302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.552838921546936},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.5424294471740723},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.5121521949768066},{"id":"https://openalex.org/C2781142857","wikidata":"https://www.wikidata.org/wiki/Q5420174","display_name":"Exhaled nitric oxide","level":4,"score":0.41333144903182983},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3893560767173767},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.2830403447151184},{"id":"https://openalex.org/C2780769369","wikidata":"https://www.wikidata.org/wiki/Q4375","display_name":"Bronchoconstriction","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2023.pa4719","doi":"https://doi.org/10.1183/13993003.congress-2023.pa4719","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa4719","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Airway pharmacology and treatment","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.550000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7129067951","https://openalex.org/W4401423116","https://openalex.org/W4404127308","https://openalex.org/W4402191222","https://openalex.org/W2167977969","https://openalex.org/W4387332708","https://openalex.org/W4408955008","https://openalex.org/W2757822157","https://openalex.org/W6907934161","https://openalex.org/W3215948619"],"abstract_inverted_index":{"Introduction:":[0],"Eosinophils":[1],"seem":[2,194],"to":[3,195,197],"play":[4],"two":[5,21],"different":[6,58,133,177],"roles:":[7],"a":[8],"physiological":[9],"and":[10,27,48,62,72,115,121,150,203],"an":[11],"inflammatory":[12,24],"role.":[13],"This":[14,40],"concept":[15],"has":[16],"raised":[17],"the":[18,43,93,179,190,208],"theory":[19],"of":[20,45,129,173,192,210],"differentiated":[22],"populations;":[23],"eosinophils":[25,29,130,180,183,211],"(iEos)":[26],"resident":[28],"(rEos).":[30],"These":[31],"differences":[32],"have":[33,144,161],"been":[34],"shown":[35],"previously":[36],"by":[37,103],"some":[38],"authors.":[39],"study":[41],"describes":[42],"effect":[44,172],"mepolizumab,":[46,81],"omalizumab":[47,82],"dupilumab":[49,151,204],"vs.":[50],"asthmatic":[51],"patients":[52,136,147,155,165],"with":[53,80,138,148,166,199],"no":[54],"biological":[55,70],"therapy":[56],"on":[57],"eosinophil":[59],"populations.":[60],"Material":[61],"methods:":[63],"Four":[64],"cohorts":[65],"were":[66,97,123,132],"collected;":[67],"asthmatics":[68,73],"without":[69,156],"treatment":[71],"treated":[74],"for":[75,106,110],"at":[76],"least":[77],"3":[78,95],"months":[79,96],"or":[83],"dupilumab.":[84],"All":[85],"subjects":[86],"who":[87],"had":[88],"taken":[89],"systemic":[90],"steroids":[91],"in":[92,134,146,153,164,178,186],"last":[94],"excluded.":[98],"Peripheral":[99],"blood":[100,188],"was":[101],"studied":[102],"flow":[104],"cytometry":[105],"surface":[107],"protein":[108],"profiles":[109],"eosinophilic":[111],"differentiation":[112],"(rEos:":[113],"Siglec-8+CD62L+IL-3Rlo":[114],"iEos:":[116],"Siglec-8+CD62LloIL-3Rhi).":[117],"The":[118,127,171,182],"IL-5":[119],"receptor":[120],"CD11b":[122,159],"also":[124],"measured":[125],"Results:":[126],"proportion":[128,209],"sub-types":[131],"asthma":[135,154],"only":[137,163],"mepolizumab":[139,149,167,193],"(Table":[140],"1).":[141,169],"IL3":[142,215],"receptors":[143,160],"decreased":[145,162],"than":[152],"monoclonal":[157,174],"antibodies.":[158],"(Figure":[168],"Conclusions:":[170],"antibodies":[175],"is":[176],"sub-types.":[181],"that":[184],"remain":[185],"peripheral":[187],"despite":[189],"use":[191],"correspond":[196],"rEos":[198],"homeostatic":[200],"functions.":[201],"Omalizumab":[202],"do":[205],"not":[206],"change":[207],"subtypes":[212],"but":[213],"decrease":[214],"receptor.":[216]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-10-28T00:00:00"}